First Blood Test for Alzheimer Biomarkers Receives FDA Clearance
This Medical News article discusses how the first FDA-cleared blood test for Alzheimer biomarkers should and shouldn’t be used.
Related Articles
Prenatal Cannabis Use and Neonatal Outcomes
This updated systematic review and meta-analysis examines whether prenatal cannabis use is associated with adverse fetal and neonatal outcomes.
Modeling Population-Level Impacts of Cell-Free DNA Screening for Colorectal Cancer in Canada
This study estimates how cell-free DNA screening impacts clinical and economic outcomes in Canada compared with existing screening approaches (fecal immunochemical tests or colonoscopies).
One-Page Patient Fact Sheets for Low Back Pain in Primary Care
This randomized clinical trial compares the effects of 1-page fact sheets that adopt either an information-listing approach or a direct advice approach on management of…
Risk Factors for COVID-19–Related Hospitalization and Death in Patients With Cancer
This prospective cohort study investigated the impact of COVID-19 on patients with cancer, including risk factors for hospitalization, treatment disruptions, and death.
Pathologic Complete Response and Survival in Rectal Cancer
This systematic review and meta-analysis examines the trial-level association between pathologic complete response and overall and disease-free survival in neoadjuvant rectal cancer randomized clinical trials.
Risk Factors for COVID-19–Related Hospitalization and Death in Patients With Cancer
This prospective cohort study investigated the impact of COVID-19 on patients with cancer, including risk factors for hospitalization, treatment disruptions, and death.
Extremely Severe Obesity and Metabolic Dysfunction in Children and Adolescents
This cross-sectional study investigates changes in the prevalence of pediatric extremely severe obesity in the US from 2008 through 2023 and the association of pediatric…
Incidence and Outcome of Cardiac Arrest Over Time
This cohort study investigates whether the incidence or outcome of out-of-hospital cardiac arrest (OHCA) is changing over time overall or among important demographic or clinical…
Early-Onset Gastrointestinal Cancers: A Review
This Review summarizes current evidence on colorectal, pancreatic, and esophagogastric cancers among individuals aged 18 to 49 years.
External Validation of an EHR-Based Model for Risk of Patient No-Show
This prognostic study evaluates the performance of an electronic health record (EHR)–based model for predicting nonattendance at primary care appointments overall and by race and…
